GRM1_HUMAN - dbPTM
GRM1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GRM1_HUMAN
UniProt AC Q13255
Protein Name Metabotropic glutamate receptor 1
Gene Name GRM1
Organism Homo sapiens (Human).
Sequence Length 1194
Subcellular Localization Cell membrane
Multi-pass membrane protein .
Protein Description G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol-calcium second messenger system. May participate in the central action of glutamate in the CNS, such as long-term potentiation in the hippocampus and long-term depression in the cerebellum..
Protein Sequence MVGLLLFFFPAIFLEVSLLPRSPGRKVLLAGASSQRSVARMDGDVIIGALFSVHHQPPAEKVPERKCGEIREQYGIQRVEAMFHTLDKINADPVLLPNITLGSEIRDSCWHSSVALEQSIEFIRDSLISIRDEKDGINRCLPDGQSLPPGRTKKPIAGVIGPGSSSVAIQVQNLLQLFDIPQIAYSATSIDLSDKTLYKYFLRVVPSDTLQARAMLDIVKRYNWTYVSAVHTEGNYGESGMDAFKELAAQEGLCIAHSDKIYSNAGEKSFDRLLRKLRERLPKARVVVCFCEGMTVRGLLSAMRRLGVVGEFSLIGSDGWADRDEVIEGYEVEANGGITIKLQSPEVRSFDDYFLKLRLDTNTRNPWFPEFWQHRFQCRLPGHLLENPNFKRICTGNESLEENYVQDSKMGFVINAIYAMAHGLQNMHHALCPGHVGLCDAMKPIDGSKLLDFLIKSSFIGVSGEEVWFDEKGDAPGRYDIMNLQYTEANRYDYVHVGTWHEGVLNIDDYKIQMNKSGVVRSVCSEPCLKGQIKVIRKGEVSCCWICTACKENEYVQDEFTCKACDLGWWPNADLTGCEPIPVRYLEWSNIESIIAIAFSCLGILVTLFVTLIFVLYRDTPVVKSSSRELCYIILAGIFLGYVCPFTLIAKPTTTSCYLQRLLVGLSSAMCYSALVTKTNRIARILAGSKKKICTRKPRFMSAWAQVIIASILISVQLTLVVTLIIMEPPMPILSYPSIKEVYLICNTSNLGVVAPLGYNGLLIMSCTYYAFKTRNVPANFNEAKYIAFTMYTTCIIWLAFVPIYFGSNYKIITTCFAVSLSVTVALGCMFTPKMYIIIAKPERNVRSAFTTSDVVRMHVGDGKLPCRSNTFLNIFRRKKAGAGNANSNGKSVSWSEPGGGQVPKGQHMWHRLSVHVKTNETACNQTAVIKPLTKSYQGSGKSLTFSDTSTKTLYNVEEEEDAQPIRFSPPGSPSMVVHRRVPSAATTPPLPSHLTAEETPLFLAEPALPKGLPPPLQQQQQPPPQQKSLMDQLQGVVSNFSTAIPDFHAVLAGPGGPGNGLRSLYPPPPPPQHLQMLPLQLSTFGEELVSPPADDDDDSERFKLLQEYVYEHEREGNTEEDELEEEEEDLQAASKLTPDDSPALTPPSPFRDSVASGSSVPSSPVSESVLCTPPNVSYASVILRDYKQSSSTL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
74PhosphorylationCGEIREQYGIQRVEA
HHHHHHHHCHHHHHH
16.0826699800
98N-linked_GlycosylationADPVLLPNITLGSEI
CCCCCCCCCCCCHHH
39.59UniProtKB CARBOHYD
103PhosphorylationLPNITLGSEIRDSCW
CCCCCCCHHHHHHCC
32.7221815630
126PhosphorylationSIEFIRDSLISIRDE
HHHHHHHHHHHCCCC
20.1127174698
129PhosphorylationFIRDSLISIRDEKDG
HHHHHHHHCCCCCCC
19.5027174698
188PhosphorylationPQIAYSATSIDLSDK
CHHHCCCEECCCCCC
21.92-
223N-linked_GlycosylationLDIVKRYNWTYVSAV
HHHHHHCCCEEEEEE
28.75UniProtKB CARBOHYD
263PhosphorylationAHSDKIYSNAGEKSF
EECCCCCCCCCHHHH
24.5523898821
339PhosphorylationVEANGGITIKLQSPE
EEECCCEEEEECCCC
18.4827050516
361PhosphorylationFLKLRLDTNTRNPWF
EEEEEECCCCCCCCC
42.9822985185
397N-linked_GlycosylationFKRICTGNESLEENY
CCCCCCCCCCHHHHH
19.96UniProtKB CARBOHYD
510PhosphorylationGVLNIDDYKIQMNKS
CCCCCHHCEEEECCC
13.2727273156
515N-linked_GlycosylationDDYKIQMNKSGVVRS
HHCEEEECCCCCCEE
20.97UniProtKB CARBOHYD
620PhosphorylationIFVLYRDTPVVKSSS
HHHHHCCCHHHCCCH
14.69-
632PhosphorylationSSSRELCYIILAGIF
CCHHHHHHHHHHHHH
12.01-
672PhosphorylationGLSSAMCYSALVTKT
HHHHHHHHHHHHHHH
5.4922817900
673PhosphorylationLSSAMCYSALVTKTN
HHHHHHHHHHHHHHH
15.3622461510
677PhosphorylationMCYSALVTKTNRIAR
HHHHHHHHHHHHHHH
32.7618187866
679PhosphorylationYSALVTKTNRIARIL
HHHHHHHHHHHHHHH
21.9918187866
695PhosphorylationGSKKKICTRKPRFMS
CCCCCCCCCCHHHHH
45.2410823959
740MethylationILSYPSIKEVYLICN
CCCCCCCCEEEEEEC
45.52-
774PhosphorylationCTYYAFKTRNVPANF
EEEEEECCCCCCCCC
22.4826074081
786PhosphorylationANFNEAKYIAFTMYT
CCCCHHHHHHHHHHH
12.4426074081
790PhosphorylationEAKYIAFTMYTTCII
HHHHHHHHHHHHHHH
10.5526074081
792PhosphorylationKYIAFTMYTTCIIWL
HHHHHHHHHHHHHHH
8.8826074081
793PhosphorylationYIAFTMYTTCIIWLA
HHHHHHHHHHHHHHH
12.3626074081
794PhosphorylationIAFTMYTTCIIWLAF
HHHHHHHHHHHHHHH
5.5726074081
853PhosphorylationVRSAFTTSDVVRMHV
CCCCCCCCCEEEEEE
25.92-
869PhosphorylationDGKLPCRSNTFLNIF
CCCCCCCCCCHHHHH
47.11-
871PhosphorylationKLPCRSNTFLNIFRR
CCCCCCCCHHHHHHH
30.64-
891UbiquitinationGNANSNGKSVSWSEP
CCCCCCCCCCCCCCC
52.51-
894PhosphorylationNSNGKSVSWSEPGGG
CCCCCCCCCCCCCCC
31.79-
969PhosphorylationDAQPIRFSPPGSPSM
CCCCCCCCCCCCCCC
21.9724076635
1091PhosphorylationTFGEELVSPPADDDD
CCCCCCCCCCCCCCC
37.48-
1109PhosphorylationRFKLLQEYVYEHERE
HHHHHHHHHHHHHCC
8.7217053785
1111PhosphorylationKLLQEYVYEHEREGN
HHHHHHHHHHHCCCC
15.6317053785
1142PhosphorylationSKLTPDDSPALTPPS
HHCCCCCCCCCCCCC
21.32-
1146PhosphorylationPDDSPALTPPSPFRD
CCCCCCCCCCCCCCC
34.95-
1149PhosphorylationSPALTPPSPFRDSVA
CCCCCCCCCCCCCCC
37.56-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
627SPhosphorylationKinaseCAMK2-FAMILY-GPS
695TPhosphorylationKinasePKC-FAMILY-GPS
695TPhosphorylationKinasePKC_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of GRM1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GRM1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
GRM1_HUMANGRM1physical
10945991
AA1R_HUMANADORA1physical
11278325
GRM1_HUMANGRM1physical
10349865
OPTN_HUMANOPTNphysical
16091361
ARBK1_HUMANADRBK1physical
16091361
HD_HUMANHTTphysical
16091361
HOME1_HUMANHOMER1physical
11418862
SRC_HUMANSRCphysical
15173175
FYN_HUMANFYNphysical
15173175
KSYK_HUMANSYKphysical
15173175

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
614831Spinocerebellar ataxia, autosomal recessive, 13 (SCAR13)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of GRM1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-672, AND MASSSPECTROMETRY.
"Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling.";
Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.;
EMBO J. 25:5058-5070(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1109 AND TYR-1111, ANDMASS SPECTROMETRY.

TOP